Detalhe da pesquisa
1.
Cellular immunotherapy combined with platinum-based chemotherapy prolongs survival for non-small cell lung cancer patients.
Neoplasma
; 70(2): 251-259, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37005956
2.
Diverse and precision therapies open new horizons for patients with advanced pancreatic ductal adenocarcinoma.
Hepatobiliary Pancreat Dis Int
; 21(1): 10-24, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34538570
3.
The surface molecular signature of leukemic cells is associated with NPM1 mutations and FLT3 -ITD in patients with de novo acute myeloid leukemia.
Acta Haematol
; 131(3): 148-52, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24192815
4.
Integrated neutrophil-to-lymphocyte ratio and handgrip strength better predict survival in patients with cancer cachexia.
Nutrition
; 122: 112399, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38493542
5.
Sarcopenia prevalence in patients with cancer and association with adverse prognosis: A nationwide survey on common cancers.
Nutrition
; 114: 112107, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37356170
6.
Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial.
Cell Res
; 33(5): 389-402, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36973538
7.
First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial.
Nat Med
; 29(8): 2079-2086, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37488286
8.
Efficacy, safety and dose selection of AZD3759 in patients with untreated EGFR-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8): a multi-center, single-arm, phase 2 trial.
EClinicalMedicine
; 64: 102238, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37781161
9.
The inositol phosphatase SHIP-1 is negatively regulated by Fli-1 and its loss accelerates leukemogenesis.
Blood
; 116(3): 428-36, 2010 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-20445019
10.
Circulating tumor DNA-minimal residual disease: An up-and-coming nova in resectable non-small-cell lung cancer.
Crit Rev Oncol Hematol
; 179: 103800, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36031171
11.
Biomarker-Driven Studies With Multi-targets and Multi-drugs by Next-Generation Sequencing for Patients With Non-Small-Cell Lung Cancer: An Open-Label, Multi-center, Phase II Adaptive Umbrella Trial and a Real-World Observational Study (CTONG1702&CTONG1705).
Clin Lung Cancer
; 23(7): e395-e399, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35659479
12.
Regulating monocyte infiltration and differentiation: Providing new therapies for colorectal cancer patients with COVID-19.
World J Clin Cases
; 9(34): 10392-10399, 2021 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35004972
13.
Cost-effectiveness analysis of first-line treatments for advanced epidermal growth factor receptor-mutant non-small cell lung cancer patients.
Cancer Med
; 10(6): 1964-1974, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33626238
14.
The promising role of antibody drug conjugate in cancer therapy: Combining targeting ability with cytotoxicity effectively.
Cancer Med
; 10(14): 4677-4696, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34165267
15.
A brand new era of cancer immunotherapy: breakthroughs and challenges.
Chin Med J (Engl)
; 134(11): 1267-1275, 2021 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34039862
16.
Correlation of circulating tumor DNA EGFR mutation levels with clinical outcomes in patients with advanced lung adenocarcinoma.
Chin Med J (Engl)
; 134(20): 2430-2437, 2021 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34669636
17.
The Chinese Thoracic Oncology Group (CTONG) therapeutic option scoring system: a multiple-parameter framework to assess the value of lung cancer treatment options.
Transl Lung Cancer Res
; 10(8): 3594-3607, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34584859
18.
Bevacizumab plus erlotinib in Chinese patients with untreated, EGFR-mutated, advanced NSCLC (ARTEMIS-CTONG1509): A multicenter phase 3 study.
Cancer Cell
; 39(9): 1279-1291.e3, 2021 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34388377
19.
Chromosome structural variation in tumorigenesis: mechanisms of formation and carcinogenesis.
Epigenetics Chromatin
; 13(1): 49, 2020 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33168103
20.
GEMSTONE-301: a phase III clinical trial of CS1001 as consolidation therapy in patients with locally advanced/unresectable (stage III) non-small cell lung cancer (NSCLC) who did not have disease progression after prior concurrent/sequential chemoradiotherapy.
Transl Lung Cancer Res
; 9(5): 2008-2015, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33209620